Medindia

X

Dehaier Medical Systems to Exhibit in International Medical Products Tradeshow FIME 2010 in Miami, Florida

Thursday, August 12, 2010 Drug News J E 4
Advertisement
BEIJING, Aug. 11 Dehaier Medical SystemsLtd. (Nasdaq: DHRM), an emerging leader in the development, assembly,marketing and sale of medical devices and homecare medical products in China,announced today that it is participating in the International FIME 2010 Showfor medical manufacturers. The company will exhibit its Homecare MedicalProducts at Booth 125 at the Miami Beach Convention Center in Miami, Floridafor three days, August 11 through August 13, 2010. Dehaier CEO Ping Chen willalso be available to meet with members of the Chinese and internationalmedical community who are gathered to attend the comprehensive medicaltradeshow.

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20100422/CNTH001LOGO )

Mr. Chen said, "We are thrilled to be participating this year in the FIMEShow, which is one of the largest medical manufacturing tradeshows for theinternational medical community. FIME draws medical distributors, hospitalpurchasing agents as well as clinicians and physicians from the U.S. and over110 countries around the world including China. The event provides Dehaiersignificant exposure to the Chinese and international medical community inattendance, as well as providing networking for distribution and allianceopportunities with manufacturers of medical technology, medical products andsupplies, medical equipment and services."

Additional information about FIME 2010 is available online athttp://www.fimeshow.com/ .

About Dehaier Medical Systems Ltd.

Dehaier Medical Systems is an emerging leader in the development, assembly,marketing and sale of medical products in China, including respiratory andoxygen homecare medical products. The company develops and assembles its ownbranded products from third party components. The company also distributesproducts designed and manufactured by other companies including medicaldevices and respiratory and oxygen homecare products from IMD (Italy), WelchAllyn (USA), Penlon (UK), HEYER (Germany), Timesco (UK), ResMed (Australia)and JMS (Japan). Dehaier's technology is based on two patents, five pendingpatents and proprietary technology. More information may be found athttp://www.chinadhr.com .

Information for investors, including an investment profile about Dehaieris available at http://www.hawkassociates.com/profile/dhrm.cfm . An onlineinvestor kit including press releases, current price quotes, stock charts andother valuable information for investors is available athttp://www.hawkassociates.com .

Forward-looking Statements

This news release contains forward-looking statements as defined by thePrivate Securities Litigation Reform Act of 1995. Forward-looking statementsinclude statements concerning plans, objectives, goals, strategies, futureevents or performance, and underlying assumptions and other statements thatare other than statements of historical facts. These statements are subject touncertainties and risks including, but not limited to, product and servicedemand and acceptance, changes in technology, economic conditions, the impactof competition and pricing, government regulation, and other risks containedin reports filed by the company with the Securities and Exchange Commission.All such forward-looking statements, whether written or oral, and whether madeby or on behalf of the company, are expressly qualified by the cautionarystatements and any other cautionary statements which may accompany theforward-looking statements. In addition, the company disclaims any obligationto update any forward-looking statements to reflect events or circumstancesafter the date hereof.For more information, please contact: Investor Contact: Hawk Associates Julie Marshall or Grace Huang Tel: +1-305-451-1888 Email: dehaier@hawkassociates.com

SOURCE Dehaier Medical Systems Ltd.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Kevin Houle, Former Technical Manager at CERT, Joi...
S
Amgen Announces Top-Line Results of Phase 3 Head a...